Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 10.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 707 shares of the medical instruments supplier’s stock after buying an additional 66 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in ICU Medical were worth $122,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of ICUI. BlackRock Inc. raised its holdings in shares of ICU Medical by 87,088.7% in the first quarter. BlackRock Inc. now owns 1,769,930 shares of the medical instruments supplier’s stock worth $270,268,000 after buying an additional 1,767,900 shares during the period. Janus Capital Management LLC raised its holdings in shares of ICU Medical by 178.8% in the first quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after buying an additional 923,395 shares during the period. Redmile Group LLC purchased a new stake in shares of ICU Medical in the first quarter worth approximately $24,515,000. Kennedy Capital Management Inc. raised its holdings in shares of ICU Medical by 255.3% in the first quarter. Kennedy Capital Management Inc. now owns 120,547 shares of the medical instruments supplier’s stock worth $18,408,000 after buying an additional 86,615 shares during the period. Finally, Wellington Management Group LLP raised its holdings in shares of ICU Medical by 12.1% in the first quarter. Wellington Management Group LLP now owns 652,897 shares of the medical instruments supplier’s stock worth $99,697,000 after buying an additional 70,283 shares during the period. Hedge funds and other institutional investors own 78.13% of the company’s stock.

In other ICU Medical news, Director Robert S. Swinney sold 463 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the transaction, the director now directly owns 14,330 shares in the company, valued at $2,597,312.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 1,784 shares of the company’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $174.47, for a total value of $311,254.48. Following the transaction, the vice president now owns 102 shares in the company, valued at $17,795.94. The disclosure for this sale can be found here. Insiders sold 213,012 shares of company stock worth $36,438,659 over the last quarter. 15.90% of the stock is currently owned by insiders.

ICU Medical, Inc. (NASDAQ ICUI) opened at 184.90 on Friday. ICU Medical, Inc. has a 12-month low of $123.77 and a 12-month high of $186.00. The firm’s 50-day moving average price is $173.09 and its 200 day moving average price is $164.39. The stock has a market capitalization of $3.66 billion, a P/E ratio of 74.05 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. During the same quarter in the prior year, the company posted $1.15 earnings per share. The company’s revenue was up 242.8% on a year-over-year basis. On average, equities analysts anticipate that ICU Medical, Inc. will post $4.11 EPS for the current year.

Several brokerages have recently weighed in on ICUI. Zacks Investment Research upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Monday, September 11th. BidaskClub downgraded ICU Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 24th. Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. Finally, Sidoti downgraded ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. ICU Medical currently has an average rating of “Hold” and a consensus price target of $193.00.

WARNING: “ICU Medical, Inc. (ICUI) Stake Raised by Zurcher Kantonalbank Zurich Cantonalbank” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/09/23/icu-medical-inc-icui-stake-raised-by-zurcher-kantonalbank-zurich-cantonalbank.html.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.